Biblioteca Humberto Rosselli Quijano
Resultado de la búsqueda
1 búsqueda de la palabra clave 'Trastorno depresivo mayor, Homocisteína, Metilenetetrahidrofolato reductasa (NADPH2), Micronutrientes, Complejo de vitamina B.'
Refinar búsqueda Générer le flux rss de la recherche
Lien permanent de la recherche
Correlation of clinical response with homocysteine reduction during therapy with reduced B vitamins in patients with MDD who are positive for MTHFR C677T or A1298C polymorphism / Arnold W. Mech en The Journal of Clinical Psychiatry, Año 2016 - Vol.77 - No.5 (Mayo)
[artículo]
Título : Correlation of clinical response with homocysteine reduction during therapy with reduced B vitamins in patients with MDD who are positive for MTHFR C677T or A1298C polymorphism : A randomized, double-blind, placebo-controlled studa Tipo de documento: texto impreso Autores: Arnold W. Mech, Autor ; Andrew Farah, Autor Fecha de publicación: 2020 Artículo en la página: pp. 668–671 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Homocisteína, Metilenetetrahidrofolato reductasa (NADPH2), Micronutrientes, Complejo de vitamina B. Resumen: This study was designed to evaluate the efficacy and safety of reduced B vitamins as monotherapy in adults with major depressive disorder (MDD) who were also positive for at least 1 methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with depression and further test the hypothesis that reduced (metabolized) B vitamins will lower homocysteine in a majority of clinically responding patients. Link: ./index.php?lvl=notice_display&id=21741
in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.5 (Mayo) . - pp. 668–671[artículo] Correlation of clinical response with homocysteine reduction during therapy with reduced B vitamins in patients with MDD who are positive for MTHFR C677T or A1298C polymorphism : A randomized, double-blind, placebo-controlled studa [texto impreso] / Arnold W. Mech, Autor ; Andrew Farah, Autor . - 2020 . - pp. 668–671.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.5 (Mayo) . - pp. 668–671
Palabras clave: Trastorno depresivo mayor, Homocisteína, Metilenetetrahidrofolato reductasa (NADPH2), Micronutrientes, Complejo de vitamina B. Resumen: This study was designed to evaluate the efficacy and safety of reduced B vitamins as monotherapy in adults with major depressive disorder (MDD) who were also positive for at least 1 methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with depression and further test the hypothesis that reduced (metabolized) B vitamins will lower homocysteine in a majority of clinically responding patients. Link: ./index.php?lvl=notice_display&id=21741